1. Introduction {#sec1}
===============

Worldwide, lung cancer is the most frequently diagnosed cancer and the leading cause of cancer-related death, with approximately 2.1 million new lung cancer cases and 1.8 million deaths \[[@B1]\]. Surgical resection is the best radical treatment for lung cancer. However, most patients have lost the chance of radical resection at the initial diagnosis and are usually treated with palliative chemotherapy and/or radiotherapy. In spite of the improvement of the treatment level, the prognosis of lung cancer patients is still poor, with a low survival rate \[[@B2]\]. Therefore, early and effective prevention strategies for lung cancer risk are quite significant.

Periodontal disease is a chronic inflammatory disease of the periodontium caused by periodontal pathogen infection, resulting in the damage of tooth-supporting tissues and finally leading to tooth loss \[[@B3]\]. Severe periodontitis is the sixth-most prevalent public health condition worldwide, which has affected approximately 10.8% of the total population \[[@B4]\]. As a chronic inflammatory disease, several studies have reported that periodontal disease has been demonstrated to increase the risk of several malignancies such as head and neck cancer \[[@B5]\], oral cancer \[[@B6], [@B7]\], digestive tract cancer \[[@B8], [@B9]\], pancreatic cancer \[[@B10]\], and prostate cancer \[[@B11]\]. Unfortunately, there are no consistent conclusions on the associations between periodontal disease, tooth loss, and lung cancer risk because some studies show positive associations, while others show null associations.

Therefore, the purpose of our meta-analysis is to evaluate whether periodontal disease and tooth loss are associated with lung cancer risk and whether prevention of periodontal disease is an effective potential prevention strategy for lung cancer.

2. Material and Methods {#sec2}
=======================

2.1. Literature Search {#sec2.1}
----------------------

A systematic literature search was performed for the relevant studies on associations between periodontal disease, tooth loss, and lung cancer risk using PubMed and Embase databases (up to September 2019). The search strategy was as follows: (periodontitis OR peridentitis OR "periodontal disease" OR "periodontal diseases" OR parodontopathy OR "gingival disease" OR "teeth number" OR "oral health" OR "dental health" OR "periodontal attachment loss" OR "periodontal pocket" OR "alveolar bone loss" OR gingivitis OR edentulous OR "tooth loss" OR "teeth loss" OR "dental plaque" OR edentulism) AND (lung cancer OR lung carcinoma OR lung tumor OR lung neoplasm). Furthermore, we manually searched the references of reviews and relevant studies to identify other eligible studies.

2.2. Eligibility Criteria {#sec2.2}
-------------------------

Included studies must meet the following eligibility criteria: (1) the exposure factor was periodontal disease and/or tooth loss; (2) the endpoint outcome was lung cancer risk; (3) the effect size of outcome was hazard ratio (HR), odds ratio (OR), or risk ratio (RR) with 95% confidence interval (CI); (4) the study type was cohort study or case-control study and the full text was available. In addition, only the most comprehensive study was included for meta-analysis if there were several duplicated studies. Some data reported only in the excluded duplicated studies were extracted into the included duplicated study for further analysis.

2.3. Data Extraction and Quality Assessment {#sec2.3}
-------------------------------------------

Two reviewers independently screened literatures and extracted data as follows: first author, study type, study name, publication country and year, follow-up time, age, type of exposure ascertainment, type of lung cancer ascertainment, sample size, number of cases, exposure type, effect size with 95% CI, and controlled confounding factors. Moreover, if the same study provided several risk estimates and these risk estimates had major gaps for confounder control, only the risk estimates with the greatest control for confounding factors were extracted for meta-analysis. The study quality of the included studies was assessed by the Newcastle-Ottawa Scale (NOS) \[[@B12]\]. Any differences on literature selection, data extraction, and quality assessment were resolved by discussion.

2.4. Statistical Analysis {#sec2.4}
-------------------------

RR with 95% CI was used as effect size to summarize the associations between periodontal disease, tooth loss, and lung cancer risk. OR value provided by case-control study could be almost equal to the RR because the lung cancer incidence was extremely low, and thus, OR was used as RR in the data synthesis \[[@B13]\]. A pooled risk estimate was synthesized for further meta-analysis when there were multiple risk estimates based on different subpopulations in one study. For the meta-analysis of tooth loss, we utilized the risk estimate which represented the most severe degree of tooth loss since there was no uniform standard for tooth loss \[[@B10]\].

To assess the impact of the number of tooth loss on lung cancer risk, we also performed a dose-response analysis which needed the assigned values of tooth loss, distributions of cases and noncases, and risk estimates in each category \[[@B14]\]. A midpoint of the interval of the tooth loss was chosen as assigned value for the risk estimate in each category. For the open-ended interval \[[@B15]\], we assumed that the range was the same as that of the adjacent interval. Restricted cubic splines were utilized to test a nonlinear dose-response relationship, and generalized least-squares regressions were used to test a linear dose-response relationship \[[@B16], [@B17]\].

The Cochran *Q* test and the *I*^2^ statistic were performed to evaluate heterogeneity among studies, and the definition of statistically significant heterogeneity was *p* \< 0.10 and/or *I*^2^ \> 50% \[[@B18]\]. A random-effect model was used when the heterogeneity was significant, and on the contrary, a fixed-effect model was chosen. The Galbraith plot was used to explore which study contributed substantial heterogeneity. The overall analysis was performed by including all studies. Subgroup analysis was performed stratified by study type, study quality, cancer ascertainment, exposure ascertainment, sample size, and country. Moreover, adequate control of confounding factors was essential to obtain valid results and to reduce misleading results, and thus, subgroup analysis based on different controlled confounding factors was conducted. Moreover, we further performed in-depth subgroup analysis not only to control for smoking but also to control for smoking amount and duration because smoking was an extremely important risk factor for lung cancer \[[@B19]\]. Publication bias was evaluated by Egger\'s and Begg\'s tests \[[@B20], [@B21]\]. In addition, a trim-and-fill analysis was conducted to evaluate the impact of publication bias on the results when publication bias existed \[[@B22]\].

All statistical analyses were conducted in Stata software version 12.0 (Stata Corporation, USA). A two-sided *p* \< 0.05 was considered statistically significant.

3. Results {#sec3}
==========

3.1. Selection of Studies {#sec3.1}
-------------------------

There were 1228 studies initially obtained from the literature search, among which 662 studies were from PubMed database and 566 studies were from Embase database. 1185 studies were excluded according to the title and abstract, and the remaining 43 studies were needed to review the full texts. After reviewing these full texts, 31 studies were excluded because these studies did not meet the eligibility criteria, and 12 studies were included for our meta-analysis \[[@B23]--[@B34]\]. The study selection process and the reasons for exclusion were shown in [Figure 1](#fig1){ref-type="fig"}.

3.2. Study Characteristics {#sec3.2}
--------------------------

The twelve studies were published from 2003 to 2019. Among these studies, five studies were from the USA, two studies were from Japan, and one study was from Turkey, Finland, Greece, Australia, and UK, respectively. In the type of study design, nine studies were cohort studies \[[@B24]--[@B28], [@B30], [@B31], [@B33], [@B34]\] and three studies were case-control studies \[[@B23], [@B29], [@B32]\]. In terms of exposure ascertainment, there were six studies using clinical periodontal examination \[[@B24], [@B26], [@B27], [@B29], [@B33], [@B34]\], and another six studies were self-reported measures \[[@B23], [@B25], [@B28], [@B30]--[@B32]\]. For the exposure factors, five studies only assessed periodontal disease \[[@B24], [@B27]--[@B30]\], three studies only assessed tooth loss \[[@B25], [@B32], [@B33]\], and four studies assessed both periodontal disease and tooth loss \[[@B23], [@B26], [@B31], [@B34]\]. For the control for confounding factors, age and sex were available in ten studies, smoking in eleven studies, alcohol drinking in eleven studies, BMI in seven studies, and diabetes in five studies. Moreover, among the included studies which have controlled for smoking, six and two studies further controlled for smoking amount and smoking duration, respectively. The main baseline characteristics of the included studies were shown in [Table 1](#tab1){ref-type="table"}.

3.3. The Association between Periodontal Disease and Lung Cancer Risk {#sec3.3}
---------------------------------------------------------------------

There were nine studies evaluating the association between periodontal disease and lung cancer risk \[[@B23], [@B24], [@B26]--[@B31], [@B34]\]. A random-effect model was used to pool RR due to a significant heterogeneity (*I*^2^ = 62.7%), and the result indicated a positive association between periodontal disease and lung cancer risk (RR = 1.37, 95% CI = 1.16‐1.63, [Figure 2](#fig2){ref-type="fig"}). The Galbraith plot showed that the study by Guven et al. contributed relatively substantial heterogeneity, and thus, we recalculated the pooled RR after excluding the study by Guven et al. \[[@B24]\]. The pooled RR with 95% CI indicated a consistent result, without significant heterogeneity (RR = 1.43, 95% CI = 1.30‐1.56, *I*^2^ = 7.3%, [Figure 2](#fig2){ref-type="fig"}). After excluding case-control studies, subgroup analysis based on cohort study also showed that periodontal disease could increase lung cancer risk (RR = 1.33, 95% CI = 1.09‐1.62). Subgroup analysis controlling for smoking indicated a positive relationship between periodontal disease and lung cancer risk (RR = 1.44, 95% CI = 1.31‐1.58), and similar results were also obtained after further controlling for smoking amount (RR = 1.40, 95% CI = 1.27‐1.54) and duration (RR = 1.86, 95% CI = 1.40‐2.48). The pooled RR with control for all potential important confounding factors (including age, sex, smoking, alcohol drinking, BMI, and diabetes) was 1.54 (95% CI = 1.34‐1.78), suggesting that periodontal disease was a strong factor for lung cancer risk ([Table 2](#tab2){ref-type="table"}).

Moreover, similar results were acquired in the subgroup analysis after dividing into groups by gender, publication country, study quality, sample size, cancer ascertainment, exposure ascertainment, and various controlled confounding factors, indicating that the periodontal disease was positively associated with lung cancer risk ([Table 2](#tab2){ref-type="table"}).

3.4. The Association between Tooth Loss and Lung Cancer Risk {#sec3.4}
------------------------------------------------------------

There were seven studies estimating the association between tooth loss and lung cancer risk \[[@B23], [@B25], [@B26], [@B31]--[@B34]\]. The result indicated that there was a positive association between tooth loss and lung cancer risk (RR = 1.69, 95% CI = 1.46‐1.96, [Figure 3](#fig3){ref-type="fig"}), without significant heterogeneity (*I*^2^ = 0.0%). In terms of study design, subgroup analysis stratified by cohort study (RR = 1.73, 95% CI = 1.46‐2.05) and case-control study (RR = 1.58, 95% CI = 1.16--2.14) also showed a positive association. Subgroup analysis based on the control for smoking status, amount, and duration obtained similar results, and the pooled RR was 1.80 after controlling for all potential important confounding factors (including age, sex, smoking, alcohol drinking, BMI, and diabetes) ([Table 2](#tab2){ref-type="table"}). Moreover, for the subgroup analysis after dividing into groups by publication country, study quality, gender, sample size, cancer ascertainment, exposure ascertainment, and various controlled confounding factors, we obtained similar results which indicated a positive relationship between tooth loss and lung cancer risk ([Table 2](#tab2){ref-type="table"}).

In addition, we performed a dose-response analysis to explore the impact of the number of tooth loss on lung cancer risk, and the result indicated that there was no nonlinear relationship (*p* for nonlinearity = 0.96). Indeed, a significant linear dose-response relationship was confirmed by the generalized least-squares regressions (*p* for linearity \< 0.01, [Figure 4](#fig4){ref-type="fig"}). Every 5 increment in tooth loss was associated with 10% increased lung cancer risk (RR = 1.10, 95% CI = 1.04‐1.17).

4. Discussion {#sec4}
=============

Lung cancer is the cancer of the highest morbidity and mortality worldwide which still have a poor prognosis even after effective treatment \[[@B1], [@B2]\]. Thus, it is urgent to find its risk factors for effective prevention. Recent studies have confirmed that periodontal disease and tooth loss are associated with several solid tumors such as oral cancer \[[@B6], [@B7]\], head and neck cancer \[[@B5]\], and pancreatic cancer \[[@B10]\]. However, the relationships between periodontal disease, tooth loss, and lung cancer risk are still controversial. Thus, we performed a meta-analysis to explore the relationships between periodontal disease, tooth loss, and lung cancer risk.

Twelve eligible studies comprising 263,238 participants were included in this meta-analysis. The results indicated that periodontal disease (RR = 1.37, 95% CI = 1.16‐1.63) and tooth loss (RR = 1.69, 95% CI = 1.46‐1.96) were positively associated with lung cancer risk. Moreover, similar results were obtained in subgroup analysis by study design, publication country, study quality, gender, sample size, cancer ascertainment, exposure ascertainment, and controlled confounding factors. The results of a dose-response analysis showed that there was a significantly linear relationship between tooth loss and lung cancer risk, and the lung cancer risk increased by 10% for 5 tooth increment in tooth loss, with a monotonically increasing trend.

In exploring the relationship between periodontal disease and lung cancer risk, four studies used self-reported measure to identify periodontal disease. Researchers may be concerned about whether self-reported periodontal disease was validated. Previous several systematic reviews have demonstrated that self-reported periodontal disease had acceptable validity and self-reported measure was feasible for monitoring periodontal disease in epidemiological studies \[[@B35], [@B36]\]. Moreover, numerous validation studies have also showed that self-reported measure was valid for the assessment of periodontal disease in different populations \[[@B37]--[@B40]\]. Indeed, the results of subgroup analysis based on self-reported periodontal disease showed that there was a positive relationship between periodontal disease and lung cancer risk (RR = 1.39, 95% CI = 1.26‐1.53), which was consistent with the results of subgroup analysis based on clinical periodontal examination. However, the adequacy for self-reported periodontal disease may depend on the education level and extent of access to routine oral healthcare in the population. Thus, the use of self-reported measure to identify periodontal disease may misclassify periodontal disease and underestimate the status of periodontal disease, which may weaken the association between periodontal disease and lung cancer risk. Future large-scale, well-designed diagnostic studies are needed to explore the validity of self-reported periodontal disease.

Periodontal disease and lung cancer were affected by many common risk factors \[[@B41], [@B42]\]. Therefore, the impact of these common confounding factors on the associations between periodontal disease, tooth loss, and lung cancer should be considered. We performed subgroup analyses based on various confounding factors, and the results confirmed the validity of our results. Among these controlled confounding factors, smoking was an extremely important risk factor for both periodontal disease and lung cancer. In order to extensively explore the impact of smoking on our results, it is essential not only to control for smoking but also to control for the smoking amount and duration, and our results still showed that there was a positive association between periodontal disease and lung cancer risk. Furthermore, a similar result was obtained after controlling for all potential important confounding factors (including age, sex, smoking, alcohol drinking, BMI, and diabetes), suggesting that periodontal disease was a strong risk factor for lung cancer risk. Future homogeneous, large-scale, and well-designed studies are needed to explore the associations between periodontal disease and lung cancer.

The mechanism of the positive relationship between periodontal disease and lung cancer was unclear. The associations between infection, inflammation, and lung cancer may be the most probable explanation \[[@B43]\]. Emerging evidence has indicated that infections could cause several types of malignant tumors, with approximately 1.2 million cases every year worldwide \[[@B44]--[@B46]\]. As a chronic inflammation caused by periodontal pathogen infections, periodontal disease could increase the levels of C-reactive protein, IL-6, IFN-*γ*, and IL-1*β* \[[@B47]--[@B49]\]. Periodontal pathogens and inflammation products entered into the bloodstream, which lead to systemic inflammatory response \[[@B50], [@B51]\]. Indeed, several studies have confirmed that high levels of C-reactive protein, IL-6, IFN-*γ*, and IL-1*β* were positively associated with lung cancer risk \[[@B52]--[@B54]\]. Dental plaque including supragingival plaque and subgingival plaque contained a good deal of bacteria in patients with periodontal disease \[[@B55]\]. Pneumonia caused by aspiration of oral bacteria may be another important mechanism \[[@B56]--[@B58]\]. Several studies have reported a positive relationship between pneumonia and lung cancer risk \[[@B59], [@B60]\]. Understandably, as a clinical indicator of periodontal disease, tooth loss could reflect the degree of poor oral health and was associated with lung cancer risk, with a linear relationship. Furthermore, further studies are required to explore the underlying mechanisms of the relationships between periodontal disease, tooth loss, and lung cancer risk.

Based on the present status that severe periodontitis and lung cancer were public health problems worldwide and there was a relationship between periodontal disease and lung cancer risk, it was a meaningful problem whether the risk of lung cancer could be reduced by effective prevention and treatment of periodontal disease \[[@B1], [@B4]\]. Some previous studies also have reported that the treatment of periodontal disease could reduce the level of inflammatory markers \[[@B61]--[@B64]\]. Moreover, Hwang et al. performed a retrospective cohort study including 116,706 periodontal disease patients to explore whether the treatment of periodontal disease could reduce the cancer risks \[[@B65]\]. The result indicated that the treatment of periodontal disease could reduce lung cancer risk in patients with periodontal disease after controlling for age, sex, occupation, type 2 diabetes mellitus, hypertension, and hyperlipidemia (RR = 0.45, 95% CI = 0.38‐0.54) \[[@B65]\]. However, this was an observational study and smoking was not controlled in the analysis, which may affect the validity of results and make it difficult to interpret the results. Therefore, there is an urgent need for large-scale, multicenter clinical studies to explore the prophylactic efficacy of treatment of periodontal disease for lung cancer risk after controlling for multiple confounding factors, especially smoking.

There was considerable heterogeneity in the meta-analysis of the association between periodontal disease and lung cancer risk. The result indicated that the study by Guven et al. contributed relatively substantial heterogeneity \[[@B24]\]. The reason may be that the number of lung cancer cases in the study was lower than that in other cohort studies due to a relatively short follow-up duration, and thus, the limited number of cases may affect the strength of the results. Moreover, the study only controlled for sex and age while the other studies also controlled for other important confounding factors as much as possible such as smoking and alcohol drinking. There was no significant heterogeneity in the meta-analysis of the association between tooth loss and lung cancer risk.

There were several limitations in our meta-analysis. First, the number of included studies was limited, which could affect the implementation of in-depth subgroup analyses. Second, the controlled confounding factors were varied, and the differences may be the potential source of heterogeneity. However, we could not completely control for all important confounding factors and eliminate the heterogeneity because the personal information could not be obtained from these published studies. Third, the exposure ascertainment of periodontal disease was discrepant. Some studies used self-reported measure to ascertain periodontal disease while the other studies used clinical periodontal examination to ascertain periodontal disease. Moreover, there was no uniform amount in the definition of tooth loss.

5. Conclusions {#sec5}
==============

Our results indicate that periodontal disease and tooth loss are positively associated with lung cancer risk. Moreover, there is a significantly linear relationship between tooth loss and lung cancer risk, with a monotonically increasing trend. Moreover, subgroup analyses based on different controlled confounding factors including smoking status, amount, and duration also confirm the validity of our results. Further large-scale, well-designed studies are urgently required to adequately control for multiple confounding factors, especially smoking, to explore the association between periodontal disease, tooth loss, and lung cancer risk.

This work was supported by Wenzhou Basic Research Project (Y20180851) by Xi Zhang.

Data Availability
=================

The data used to support the findings of this study are available from the corresponding author upon request.

Disclosure
==========

The sponsors had no role in study design, data collection, data analysis, data interpretation, writing of the report, or the decision to submit the paper for publication. The corresponding author had full access to all the data and analyses.

Conflicts of Interest
=====================

The authors declare that there is no conflict of interest regarding the publication of this paper.

![Process of literature search and study selection.](BMRI2020-5107696.001){#fig1}

![Result of the association between periodontal disease and lung cancer risk: (a) all studies; (b) excluding the study by Guven et al.](BMRI2020-5107696.002){#fig2}

![Result of the association between tooth loss and lung cancer risk.](BMRI2020-5107696.003){#fig3}

![A linear dose-response relationship between tooth loss and lung cancer risk.](BMRI2020-5107696.004){#fig4}

###### 

Baseline characteristics of the included studies.

  Article              Country and year   Study design         Exposure measure   Cancer measure   Age (year)                  Follow up (year)           Sample size   Case   Type of exposure                       Adjusted variables                                                                                                                                                                                                                               Study quality
  -------------------- ------------------ -------------------- ------------------ ---------------- --------------------------- -------------------------- ------------- ------ -------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------
  Guven                Turkey 2019        Cohort study         Exam               Incidence        Median: 57.7                Median: 7.2                5199          32     Periodontal disease                    Age and sex                                                                                                                                                                                                                                      5
  Yoon                 USA 2019           Case-control study   Self-reported      Incidence        40-79                       NR                         2015          403    Periodontal disease; tooth loss        BMI, education, household income, COPD, alcohol drinking, smoking status, pack-years, and missing data on oral health                                                                                                                            6
  Goto                 Japan 2019         Cohort study         Self-reported      Mortality        35-70                       Median: 10.2               11273         113    Remaining teeth                        Age, sex, BMI, pack-years of smoking, alcohol consumption, education level, marital status, physical exercise, and medical history of hypertension and diabetes mellitus                                                                         7
  Heikkila             Finland 2018       Cohort study         Exam               Mortality        Mean: 43                    Mean: 10.1                 68273         161    Periodontal disease                    Calendar time, age, sex, socioeconomic status, number of teeth, dental treatments, oral health indices, need of periodontal treatment, and diabetes                                                                                              7
  Michaud              USA 2018           Cohort study         Exam               Incidence        44-66                       Mean: 14.7                 7466          226    Periodontal disease; edentulism        Age, field center, education level, smoking status, smoking duration, drinking status, BMI, diabetes status, sex, HRT use, and race                                                                                                              8
  Nwizu                USA 2017           Cohort study         Self-reported      Incidence        54-86                       Mean: 8.32 ± 3.95          65869         855    Periodontal disease                    Age, pack-years, and BMI                                                                                                                                                                                                                         5
  Chrysanthakopoulos   Greece 2016        Case-control study   Exam               Incidence        Mean: 61.4 ± 4.2            NR                         200           64     Periodontal disease                    Gender, smoking, socioeconomic level, educational level, age, cancer family history, history of previous pulmonary disease, and annual dental follow-up                                                                                          6
  Arora                Australia 2010     Cohort study         Self-reported      Incidence        Median: 51 (range: 38-77)   Median: 27 (range: 1-41)   15333         225    Periodontal disease                    Sex, age, education, employment, number of siblings, smoking status, smoking status of partner, alcohol status, diabetes, and BMI                                                                                                                5
  Michaud              USA 2008           Cohort study         Self-reported      Incidence        Range: 40-75                Median: 17.7               48375         678    Periodontal disease; number of teeth   Age, ethnic origin, physical activity, history of diabetes, alcohol, BMI, geographical location, height, calcium intake, total calorific intake, red-meat intake, fruit and vegetable intake, vitamin D score, smoking history, and pack-years   5
  Hiraki               Japan 2008         Case-control study   Self-reported      Incidence        58                          NR                         15720         909    Remaining teeth                        Age, sex, smoking and drinking status, vegetable and fruit intake, BMI, and regular exercise                                                                                                                                                     5
  Tu                   UK 2007            Cohort study         Exam               Mortality        Median: 19 (IQR: 3)         Mean: 46 ± 12              12223         NR     Tooth loss                             Baseline smoking status                                                                                                                                                                                                                          4
  Hujoel               USA 2003           Cohort study         Exam               Mortality        Range: 25-74                About 17-21                11328         191    Periodontal disease; edentulism        Age, gender, poverty index, education, race, smoking duration and packs per day, cigar smoking, passive smoke, vitamins A & C and alcohol sampling design                                                                                        7

BMI: body mass index; COPD: chronic obstructive pulmonary disease; HRT: hormone replacement therapy; IQR: interquartile range; NR: not reported; UK: United Kingdom; USA: United States of America.

###### 

The results for the associations between periodontal disease, tooth loss, and lung cancer risk.

                                                   *N*   RR                 *p* ~RR~   Heter    Publication bias
  ------------------------------------------------ ----- ------------------ ---------- -------- -------------------------------------------
  Periodontal disease                                                                           
  Overall                                          9     1.37 (1.16-1.63)   \<0.001    62.70%   Begg′s test = 0.602; Egger′s test = 0.771
   Overall without Guven                           8     1.43 (1.30-1.56)   \<0.001    7.30%    Begg′s test = 0.386; Egger′s test = 0.168
  Study type                                                                                    
   Cohort                                          7     1.33 (1.09-1.62)   0.004      68.80%   Begg′s test = 1.000; Egger′s test = 0.880
   Cohort without Guven                            6     1.42 (1.29-1.56)   \<0.001    13.10%   Begg′s test = 0.707; Egger′s test = 0.460
   Case-control study                              2     1.52 (1.16-1.98)   0.002      37.00%   Begg′s test = 1.000; Egger\'s test = /
  Cancer ascertainment                                                                          
   Cancer incidence                                7     1.37 (1.12-1.68)   0.002      70.40%   Begg′s test = 0.764; Egger′s test = 0.834
   Cancer incidence without Guven                  6     1.43 (1.30-1.57)   \<0.001    21.00%   Begg′s test = 0.452; Egger′s test = 0.127
   Cancer mortality                                3     1.22 (1.02-1.45)   0.027      0.00%    Begg′s test = 0.296; Egger′s test = 0.374
  Exposure ascertainment                                                                        
   Exam                                            5     1.41 (0.90-2.21)   0.135      79.70%   Begg′s test = 0.806; Egger′s test = 0.493
   Exam without Guven                              4     1.65 (1.32-2.07)   \<0.001    30.30%   Begg′s test = 1.000; Egger′s test = 0.637
   Self-reported                                   4     1.39 (1.26-1.53)   \<0.001    0.00%    Begg′s test = 1.000; Egger′s test = 0.719
  Sample size                                                                                   
   \<12000                                         5     1.46 (0.96-2.21)   0.075      79.70%   Begg′s test = 0.806; Egger′s test = 0.613
   \<12000 without Guven                           4     1.67 (1.37-2.03)   \<0.001    0.00%    Begg′s test = 0.308; Egger′s test = 0.278
   ≥12000                                          4     1.37 (1.24-1.51)   \<0.001    0.00%    Begg′s test = 0.734; Egger′s test = 0.816
  Country                                                                                       
   Not Asia                                        8     1.43 (1.30-1.56)   \<0.001    7.30%    Begg′s test = 0.386; Egger′s test = 0.168
  Sex                                                                                           
   Male                                            3     1.19 (0.65-2.17)   0.575      88.80%   Begg′s test = 1.000; Egger′s test = 0.717
   Female                                          3     1.34 (1.17-1.52)   \<0.001    0.00%    Begg′s test = 1.000; Egger′s test = 0.772
  Study quality                                                                                 
   ≥7                                              3     1.60 (1.27-2.03)   \<0.001    37.2%    Begg′s test = 1.000; Egger′s test = 0.871
   \<7                                             6     1.30 (1.05-1.59)   0.014      69.1%    Begg′s test = 1.000; Egger′s test = 0.927
  Adjusted variables                                                                            
   Sex+age                                         8     1.37 (1.12-1.67)   0.002      67.10%   Begg′s test = 0.536; Egger′s test = 0.807
   Smoking                                         7     1.44 (1.31-1.58)   \<0.001    11.60%   Begg′s test = 0.368; Egger′s test = 0.072
   Alcohol drinking                                5     1.53 (1.36-1.73)   \<0.001    0.00%    Begg′s test = 0.462; Egger′s test = 0.506
   BMI                                             5     1.42 (1.30-1.56)   \<0.001    12.3%    Begg′s test = 0.806; Egger′s test = 0.346
   Diabetes                                        4     1.50 (1.31-1.71)   \<0.001    9.3%     Begg′s test = 1.000; Egger′s test = 0.961
   Smoking+alcohol drinking                        5     1.53 (1.36-1.73)   \<0.001    0.00%    Begg′s test = 0.462; Egger′s test = 0.506
   Smoking+alcohol drinking+sex+age                4     1.55 (1.36-1.78)   \<0.001    0.00%    Begg′s test = 1.000; Egger′s test = 0.530
   Smoking+alcohol drinking+sex+age+BMI+diabetes   3     1.54 (1.34-1.78)   \<0.001    0.0%     Begg′s test = 1.000; Egger′s test = 0.741
  Adjusted smoking factor                                                                       
   Amount of smoking                               5     1.40 (1.27-1.54)   \<0.001    0.0%     Begg′s test = 1.000; Egger′s test = 0.354
   Duration of smoking                             2     1.86 (1.40-2.48)   \<0.001    0.0%     Begg′s test = 1.000; Egger\'s test = /
  Tooth loss                                                                                    
  Overall                                          7     1.69 (1.46-1.96)   \<0.001    0.00%    Begg′s test = 0.368; Egger′s test = 0.868
  Study type                                                                                    
   Cohort                                          5     1.73 (1.46-2.05)   \<0.001    0.00%    Begg′s test = 0.462; Egger′s test = 0.956
   Case-control study                              2     1.58 (1.16-2.14)   0.003      0.00%    Begg′s test = 1.000; Egger\'s test = /
  Cancer ascertainment                                                                          
   Cancer incidence                                4     1.73 (1.47-2.05)   \<0.001    0.00%    Begg′s test = 0.308; Egger′s test = 0.599
   Cancer mortality                                3     1.54 (1.10-2.14)   0.011      0.00%    Begg′s test = 0.296; Egger′s test = 0.011
  Exposure ascertainment                                                                        
   Exam                                            3     1.80 (1.28-2.54)   0.001      38.00%   Begg′s test = 0.296; Egger′s test = 0.028
   Self-reported                                   4     1.67 (1.41-1.97)   \<0.001    0.00%    Begg′s test = 0.734; Egger′s test = 0.679
  Sample size                                                                                   
   \<12000                                         4     1.82 (1.40-2.37)   \<0.001    0.00%    Begg′s test = 0.734; Egger′s test = 0.605
   ≥12000                                          3     1.63 (1.36-1.96)   \<0.001    0.00%    Begg′s test = 0.296; Egger′s test = 0.043
  Country                                                                                       
   Asia                                            2     1.62 (1.20-2.19)   0.002      0.00%    Begg′s test = 1.000; Egger\'s test = /
   Not Asia                                        5     1.72 (1.45-2.04)   \<0.001    0.00%    Begg′s test = 0.221; Egger′s test = 0.902
  Sex                                                                                           
   Male                                            3     1.66 (1.15-2.41)   0.007      70.40%   Begg′s test = 1.000; Egger′s test = 0.637
   Female                                          2     1.49 (1.02-2.19)   0.040      0.00%    Begg′s test = 1.000; Egger\'s test = /
  Study quality                                                                                 
   ≥7                                              3     1.90 (1.39-2.58)   \<0.001    17.2%    Begg′s test = 1.000; Egger′s test = 0.643
   \<7                                             4     1.64 (1.38-1.94)   \<0.001    0.0%     Begg′s test = 0.308; Egger′s test = 0.140
  Adjusted variables                                                                            
   Sex+age                                         5     1.72 (1.47-2.02)   \<0.001    0.00%    Begg′s test = 1.000; Egger′s test = 0.827
   Smoking                                         7     1.69 (1.46-1.96)   \<0.001    0.00%    Begg′s test = 0.368; Egger′s test = 0.868
   Alcohol drinking                                6     1.71 (1.47-2.00)   \<0.001    0.00%    Begg′s test = 1.000; Egger′s test = 0.861
   BMI                                             5     1.74 (1.48-2.03)   \<0.001    0.0%     Begg′s test = 0.221; Egger′s test = 0.537
   Diabetes                                        3     1.80 (1.50-2.16)   \<0.001    4.7%     Begg′s test = 0.296; Egger′s test = 0.478
   Smoking+alcohol drinking                        6     1.71 (1.47-2.00)   \<0.001    0.00%    Begg′s test = 1.000; Egger′s test = 0.861
   Smoking+alcohol drinking+sex+age                5     1.72 (1.47-2.02)   \<0.001    0.00%    Begg′s test = 1.000; Egger′s test = 0.827
   Smoking+alcohol drinking+sex+age+BMI+diabetes   3     1.80 (1.50-2.16)   \<0.001    4.7%     Begg′s test = 0.296; Egger′s test = 0.478
  Adjusted smoking factor                                                                       
   Amount of smoking                               4     1.67 (1.40-1.99)   \<0.001    0.0%     Begg′s test = 0.089; Egger′s test = 0.387
   Duration of smoking                             2     1.93 (1.05-3.57)   0.035      55.3%    Begg′s test = 1.000; Egger\'s test = /

Heter: heterogeneity; BMI: body mass index; *N*: the number of studies; RR: risk ratio; *p*~RR~: *p* value for the risk ratio; "/": not applicable because Egger\'s test could not be conducted if the study number was only two.

[^1]: Academic Editor: Noriyoshi Sawabata
